Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dopa-responsive dystonia

T G Nygaard1

  • 1Department of Neurology, Columbia University, New York, USA.

Current Opinion in Neurology
|August 1, 1995
PubMed
Summary
This summary is machine-generated.

Recent advances clarify dopa-responsive dystonia (DRD), distinguishing it from parkinsonism and identifying genetic causes. Research highlights infantile manifestations and the condition's developmental nature, with new gene mutation discoveries.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A novel autosomal dominant limb-girdle muscular dystrophy (LGMD 1F) maps to 7q32.1-32.2.

Neurology·2003
Same author

Clinical characteristics of a family with chromosome 17-linked disinhibition-dementia-parkinsonism-amyotrophy complex. 1994.

Neurology·2002
Same author

Response to levodopa treatment in dopa-responsive dystonia.

Archives of neurology·2001
Same author

Mitochondrial neurogastrointestinal encephalomyopathy: an autosomal recessive disorder due to thymidine phosphorylase mutations.

Annals of neurology·2000
Same author

Gaucher disease: the origins of the Ashkenazi Jewish N370S and 84GG acid beta-glucosidase mutations.

American journal of human genetics·2000
Same author

Localization of a gene for myoclonus-dystonia to chromosome 7q21-q31.

Annals of neurology·1999
Same journal

Movement disorders and Parkinson's disease: collaborative and interdisciplinary research to advance understanding of neural circuit dysfunction, pathophysiology, and care: new horizons in technology, neuroimaging, neurophysiology, and genetics toward personalized medicine.

Current opinion in neurology·2026
Same journal

Editorial introduction.

Current opinion in neurology·2026
Same journal

Multimodal mapping of balance dysfunction in Parkinson's disease: a consensus roadmap for research and intervention.

Current opinion in neurology·2026
Same journal

Tourette syndrome: brain neurophysiology, circuit dysfunction, and neuromodulation across invasive and noninvasive approaches.

Current opinion in neurology·2026
Same journal

Dystonia: from phenotypes to genetics and therapeutic advances.

Current opinion in neurology·2026
Same journal

What can we learn from eye movements in movement disorders and Parkinson's disease?

Current opinion in neurology·2026
See all related articles

Area of Science:

  • Neuroscience
  • Genetics
  • Pediatric Neurology

Background:

  • Dopa-responsive dystonia (DRD) is a rare neurological disorder.
  • Recent research has significantly advanced understanding of DRD over the past 18 months.
  • Distinguishing DRD from other movement disorders, like childhood-onset parkinsonism, remains a clinical challenge.

Purpose of the Study:

  • To summarize recent key findings in dopa-responsive dystonia.
  • To highlight advances in clinical, pathophysiological, and genetic aspects of DRD.
  • To differentiate DRD from childhood-onset parkinsonism.

Main Methods:

  • Clinical investigations to broaden the disease spectrum, focusing on infantile presentations.
  • Pathophysiological studies to identify distinguishing features from childhood-onset parkinsonism.

Related Experiment Videos

  • Genetic analyses to identify mutations in genes associated with DRD.

    • Main Results:

    • Clinical studies revealed a broader spectrum of DRD, including infantile manifestations.
    • Pathophysiological findings help distinguish DRD from childhood-onset parkinsonism.
    • Mutations in GTP cyclohydrolase I gene identified for autosomal dominant DRD.
    • Mutations in tyrosine hydroxylase gene suggest an autosomal recessive form of DRD.

    Conclusions:

    • Significant progress has been made in understanding dopa-responsive dystonia.
    • Genetic mutations in GTP cyclohydrolase I and tyrosine hydroxylase are linked to DRD.
    • The 'developmental' nature of DRD is pathologically confirmed.